Endometriosis CARE Act of 2022
Latest action (7 Jun 2022): Introduced
What this bill does
The Endometriosis CARE Act of 2022 would direct federal health agencies to expand research, data collection, and public education related to endometriosis, a chronic gynecological condition. It authorizes the National Institutes of Health to fund research, treatment studies, and an information clearinghouse ($30 million annually for fiscal years 2023–2027). It also directs the Secretary of Health and Human Services to study barriers patients face in accessing treatment, including reviewing Medicaid, CHIP, and private insurance data, and to report findings to Congress. Additionally, it requires public education campaigns on endometriosis awareness and symptoms, information for health care providers on diagnosis and treatment, and a National Academies of Sciences, Engineering, and Medicine study on disparities in endometriosis care by race, geography, language, sexual orientation, gender identity, disability, and insurance status.
The bill primarily affects patients with endometriosis, health care providers, insurers, and state Medicaid/CHIP programs, which may be required to report certain data. It aims to improve understanding of the condition, reduce diagnostic and treatment disparities, and strengthen provider and patient education, particularly for underserved populations.
The bill was introduced on June 7, 2022, by Rep. Lauren Underwood and referred to the House Committee on Energy and Commerce. It did not receive a vote and did not become law during the 117th Congress. As with all unenacted bills, it would need to be reintroduced in a future Congress to be considered again.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Endometriosis Coverage, Awareness, Research, and Education Act of 2022 or the Endometriosis CARE Act of 2022
This bill requires the Department of Health and Human Services (HHS) to address endometriosis through increasing awareness, research, and other means. Endometriosis is a condition in which tissue similar to the inner lining of the uterus grows outside of the uterus, which may result in pain, infertility, and other symptoms.
Specifically, HHS must
• report on barriers (e.g., issues related to health insurance coverage and costs) to accessing endometriosis care and treatments;
• disseminate information about endometriosis, such as its symptoms and treatments, to both the public and health care providers; and
• seek to contract with the National Academies of Sciences, Engineering, and Medicine to study racial, ethnic, and other disparities in endometriosis prevalence, diagnosis, treatment, and outcomes.
The National Institutes of Health must also conduct or support data collection, surveillance, and research related to endometriosis.
Common questions
- What does H.R. 7974 do?
- The Endometriosis CARE Act of 2022 would direct federal health agencies to expand research, data collection, and public education related to endometriosis, a chronic gynecological condition. It authorizes the National Institutes of Health to fund research, treatment studies, and an information clearinghouse ($30 million annually for fiscal years 2023–2027). It also directs the Secretary of Health and Human Services to study barriers patients face in accessing treatment, including reviewing Medicaid, CHIP, and private insurance data, and to report findings to Congress. Additionally, it requires public education campaigns on endometriosis awareness and symptoms, information for health care providers on diagnosis and treatment, and a National Academies of Sciences, Engineering, and Medicine study on disparities in endometriosis care by race, geography, language, sexual orientation, gender identity, disability, and insurance status. The bill primarily affects patients with endometriosis, health care providers, insurers, and state Medicaid/CHIP programs, which may be required to report certain data. It aims to improve understanding of the condition, reduce diagnostic and treatment disparities, and strengthen provider and patient education, particularly for underserved populations. The bill was introduced on June 7, 2022, by Rep. Lauren Underwood and referred to the House Committee on Energy and Commerce. It did not receive a vote and did not become law during the 117th Congress. As with all unenacted bills, it would need to be reintroduced in a future Congress to be considered again.
- Has H.R. 7974 become law?
- Not yet. As of 7 Jun 2022, H.R. 7974 is introduced.
- Who sponsored H.R. 7974?
- H.R. 7974 was sponsored by Rep. Lauren Underwood [D-IL14] (Democrat-IL), with 11 cosponsors.
- What's the latest action on H.R. 7974?
- Introduced (7 Jun 2022).
Related bills in Health
Expressing support for the designation of September 22, 2026, as “National Hispanic Nurses Day” and recognizing the National Association of Hispanic Nurses as the leading organization representing and advocating for Hispanic nurses.
Recognizing the importance of protecting continuous Medicaid coverage for individuals undergoing active cancer treatment.
Wildland Firefighter Health and Safety Act
Expressing support for the designation of the third week of September as “Fungal Disease Awareness Week” and encouraging efforts to improve awareness, diagnosis, treatment, surveillance, and prevention of fungal diseases in the United States.
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.